All articles by Staff Writer
Staff Writer
Pandemic prevention: progress in research infrastructure
Interview with Prof. Claudia Traidl-Hoffmann, Director of the Institute of Environmental Medicine, Helmholtz Munich, and Professor of Environmental Medicine at the University of Augsburg
Roche launches a new addition to the cobas® connection modules, the CCM Vertical, helping to improve laboratory efficiency
Roche announced today that it has a new addition to the cobas® connection modules (CCM), the CCM Vertical, allowing transportation of samples on overhead conveyors.* This solution allows for CCM conveyors to cross walkways, connecting different work areas and keeps (emergency) exits accessible. Samples can also be transported up or down to different levels.
Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective
TB is one of the world’s deadliest diseases, killing about 4,300 people per day, mostly those living in poverty
India’s G20 Presidency Drives Global Digital Health Initiative for Accessible and Equitable Global Healthcare
The spotlight is poised to shine on India as the G20 Health Minister’s Meeting, under India’s G20 Presidency, kicks off from 17 to 19 August 2023 in Gandhinagar, Gujarat, India. The prestigious gathering promises impactful discussions on global health collaboration and the launch of a Global Initiative on Digital Health.
Heart Failure start-up, Acorai, embarks on the next vital stage towards regulatory approval
Today, Acorai, a start-up medical device manufacturer from Sweden, has announced the initiation of a global clinical trial with the enrollment of its first patient in London, UK. Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024.
Masimo SedLine Psi improves brain monitoring for certain sedated patients in study
According to the company, Masimo PSi, which is a SedLine parameter from electroencephalographic data, was found statistically and significantly related to dexmedetomidine dosage
Teleflex secures expanded FDA approval for QuikClot Control+ haemostatic device
The FDA approval expands the use of QuikClot Control+ haemostatic device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy, including patients on anticoagulation or antiplatelet medication
Abbott secures FDA approval for Alinity H-Series haematology system
The Alinity h-series system includes an integrated slide maker and stainer Alinity hs, and an automated haematology analyser Alinity hq, which deploys the advanced MAPSS technology to better identify various blood cells
First Patient Dosed in IPAX-2 Study of TLX101 Brain Cancer Therapy Candidate in Patients with Newly Diagnosed Glioblastoma
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase I study of the Company’s investigational therapy TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) in combination with post-surgical standard of care treatment in patients with newly diagnosed glioblastoma, the most common and aggressive form of primary brain cancer.
SEKISUI Diagnostics unveils OSOM Covid-19 antigen home test
OSOM Covid-19 antigen home test is a lateral flow immunoassay tool, designed for the qualitative identification of SARS-CoV-2 virus nucleocapsid protein antigen